Changzhou Jinchengrui Chemical Co., LTD

The company adheres to the purpose of scientific and technological innovation leading the development of enterprises, constantly strengthens research and development construction, takes industrial transformation and upgrading and scientific and technological innovation as the carrier, and builds into a first-class titanium dioxide group in China

vke mold technology co.,ltd

VKE Mold Tech Co Ltd provides one stop solution for Plastic Injection Mold design, manufacturing, tryout, mass production, assembly, testing & validation under one roof. Some Synopsis IATF 16949:2016 and ISO 9001:2015 . Specializes in manufacturing of high precision injection moulds and production of injection molded components. Qualified and experienced manpower from reputed institutes. Internationally competitive products with respect to quality, cost, lead time and reliability. Premium quality Tool steels, hardened through vacuum technology are used toenhance tool performance. Critical machines installed in dust free and controlled environment. Catering to Automotive, Electrical, Switchgear, Medical, Consumer Durables and FMCG segments.

3D Medicines Inc

3D Medicines Inc. is a leading innovative biopharmaceutical company and committed to the development and commercialization of next generation of immuno-oncology (I/O) therapies with differentiated clinical benefit in response to the trend of treating cancer as a chronic disease. The mission is to help prolong the survival of cancer patients and improve their quality of life. The visionary management team has led us to build industry-leading, fully-integrated capabilities in end-to-end drug R&D from pre-clinical discovery to clinical development and commercialization. The core product envafolimab is a global first and only BLA-stage, subcutaneously-injectable PD-L1 antibody that has the potential to address a global unmet medical need for the treatment of cancer as a chronic disease. With a robust I/O monotherapy and combo-therapy portfolio of more than 10 drug candidates with envafolimab as the backbone, we strive to become a leader in the chronic cancer treatment market. For more information, please visit www.3d-medicines.com.

Zhejiang Samsung Down Co., Ltd

Established in 1988, Zhejiang Samsung Down Co., Ltd is awarded as one of the Top Ten Meritorious Enterprises in China's Down Industry. Zhejiang Samsung Down owns multiple brands, manufacturers, and trade companies. Samsung Down has developed its whole industrial chain, including raw material, manufacturing, sales, and export. Samsung Down has focused on the R & D of new products for various scenarios since its establishment more than 30 years ago. Samsung Down is honored with numerous technological achievements. Samsung Down is the first company that is allowed to use the mark of “ZHEJIANG MADE” in the down industry; it is also one of the first enterprises certified as National High-Tech Enterprise. Samsung Down is China QB down standard drafter; Vice president of China Feather & Down Industrial Association; Vice-chairman enterprise of Zhejiang Down Industrial Association; Supervisory Board member of International Down & Feather Bureau (IDFB); Public Relation Committee member of IDFB; and Technical Commission member of IDFB. Samsung Down has acquired dozens of international certifications such as Oeko-Tex Standard 100, RDS, DOWNPASS, GRS, CNAS, BSCI, etc. Accredit to its cutting-edge developing technology and its excellent reputation in the global down industry, “Samsung Made” has become an assurance of exceptional product quality. Samsung Down has strategic partners over 30 countries around the globe, and it has been awarded as the top ten export enterprises in the Chinese down & feather industry for more than ten consecutive years.

Triastek, Inc.

Triastek is a global leader in 3D printing pharmaceuticals, pioneering the next generation of digital pharmaceutical processes. Founded in July 2015, Triastek is dedicated to the mission of "revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide." We have created the Melt Extrusion Deposition (MED®) 3D printing pharmaceutical process, transforming the delivery, development, and production of medication through digital product development and continuous manufacturing. Leveraging our proprietary 3D printing pharmaceutical technology, we design and develop transformative medications for patients. Through collaboration with global pharmaceutical companies, we tackle challenging formulation issues, accelerating the development of new drug products and improving the quality of pharmaceuticals. Our vision is to become the world's most influential intelligent pharmaceutical enterprise.